5 hours Soleno Therapeutics (NASDAQ:SLNO) Price Target Raised to $74.00 at Stifel Nicolaus MarketBeat
Stifel Nicolaus upped their price target on shares of Soleno Therapeutics from $59.00 to $74.00 and gave the company a “buy” rating in a report on Tuesday.